Utilizing HR-HPV testing of vaginal self-collected specimens as a primary screen for prevention of cervical cancer has significant advantages when compared to endocervical clinician-collected specimens tested for HR-HPV or cervical cytology. Its greatest advantage is the ease with which a single individual can instruct the women and gather hundreds of self-collected samples/day.